<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Tuebingen_Project_Motivation"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Tuebingen/Project/Motivation">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Tuebingen/Project/Motivation&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Tuebingen/Project/Motivation&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Tuebingen/Project/Motivation&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Tuebingen/Project/Motivation" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Tuebingen/Project/Motivation</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV id="wrapper"><NAV><UL><LI class="cat1"><A href="#">Home</A></LI><LI class="cat2"><A href="#">Project</A></LI><LI><A href="#">Overview</A></LI><LI><A href="#">Motivation</A></LI><LI><A href="#">Inteins</A></LI><LI><A href="#">Enzymes</A></LI></UL><LI class="cat3"><A href="#">Team</A></LI><LI><A href="#">About Us</A></LI><LI><A href="#">Attributions</A></LI><LI class="cat4"><A href="#">Notebook</A></LI><LI><A href="#">Protocols</A></LI><LI><A href="#">Lab Journal</A></LI><LI class="cat5"><A href="#">Activities</A></LI><LI><A href="#">SynBio-Day</A></LI><LI><A href="#">School-Project</A></LI><LI><A href="#">Aachen Conference</A></LI><LI class="cat6"><A href="#">Results</A></LI><LI><A href="#">Shipped Parts</A></LI><LI class="cat7"><A href="#">Contact</A></LI></NAV></DIV><P><NAV><UL><LI class="cat1"><A href="/Team:Tuebingen">Home</A></LI><LI class="cat2"><A href="#">Project</A></LI><LI><A href="/Team:Tuebingen/Project/Overview">Overview</A></LI><LI><A href="/Team:Tuebingen/Project/Motivation">Motivation</A></LI><LI><A href="/Team:Tuebingen/Project/Plasmids">Plasmids</A></LI><LI><A href="/Team:Tuebingen/Project/ImmobilizationTags">Immobilization Tags</A></LI><LI><A href="/Team:Tuebingen/Project/SyntheticPeptides">Synthetic Peptides</A></LI><LI><A href="/Team:Tuebingen/Project/Enzymes">Enzymes</A></LI><LI><A href="/Team:Tuebingen/Project/Applications">Applications</A></LI><LI><A href="/Team:Tuebingen/Project/Safety">Safety</A></LI></UL><LI class="cat8"><A href="#">Collaboration</A></LI><LI><A href="/Team:Tuebingen/Collaboration/Intellectual_Property">Intellectual property</A></LI><LI><A href="/Team:Tuebingen/Collaboration/TeamHeidelberg">Team Heidelberg</A></LI><LI><A href="/Team:Tuebingen/Collaboration/TeamUiOslo">Team Ui Oslo</A></LI><LI class="cat3"><A href="#">Team</A></LI><LI><A href="/Team:Tuebingen/Team/About">About Us</A></LI><LI><A href="/Team:Tuebingen/Team/Acknowledgements">Acknowledgements</A></LI><LI><A href="/Team:Tuebingen/Team/Attributions">Attributions</A></LI><LI class="cat4"><A href="#">Notebook</A></LI><LI><A href="/Team:Tuebingen/Notebook/Protocols">Protocols</A></LI><LI><A href="/Team:Tuebingen/Notebook/Journal">Lab Journal</A></LI><LI class="cat5"><A href="#">Activities</A></LI><LI><A href="/Team:Tuebingen/Activities/SynBioDay">SynBioDay</A></LI><LI><A href="/Team:Tuebingen/Activities/SchoolProject">School-Project</A></LI><LI><A href="/Team:Tuebingen/Activities/AachenMeetup">Aachen Meetup</A></LI><LI class="cat6"><A href="#">Results</A></LI><LI><A href="/Team:Tuebingen/Results/BioBricks">Shipped Parts</A></LI><LI><A href="/Team:Tuebingen/Results/Modeling">Modeling</A></LI><LI><A href="/Team:Tuebingen/Results/Characterization">Characterization</A></LI><LI class="cat7"><A href="/Team:Tuebingen/Contact">Contact</A></LI></NAV></P><DIV id="TueContent"><H1>Motivation</H1><P>
This year the work of iGEM Team Tübingen on the T-ECO project was all about the conversion of blood types to provide
an improved blood supply for patients in emergency and to thereby save lives.
</P><P>
The human blood can be classified into several groups based on the presence of certain antigenic 
structures on the surface of red blood cells. In total <A href="http://www.uvm.edu/~uvmpr/?Page=news&amp;storyID=13259">33 blood-group systems have been identified [1]</A>, 
while the ABO system is the most important system in human-blood transfusion.
</P><P id="picText">Figure 1: ABO blood type system. Oligosaccharide structures on red blood cells act as antigens.
Based on the oligosaccharide of group O, group A contains an additional N acetyl-galactosamine 
and group B has an additional Galactose attached to it. Red blood cells from group AB carry both 
types of oligosaccharides [2].</P><P>
While the plasma of group A contains antibodies against antigens of group B and the other way
round, the plasma of group O contains both antibodies. In the case of group AB no antibodies against 
an A or B antigen are present. This properties directly explain the compatibility of blood groups in the 
case of a blood transfusion, as shown in Table 1.
</P><DIV align="center">Table 1: Compatibility of ABO blood groups for blood transfusion.</DIV><P>
By referring to the blood group compatibility it is obvious that blood group O is the optimal donor 
blood for blood transfusion. And patients from the other groups can be supplied with blood 
preservations of at least one additional type. On the other hand patients from group O are 
dependent on a supply of blood type O only. The blood type distribution of the population in the USA 
for example is as follows: 44 % of the population is type O, 42 % is type A, 10 % is type AB and 4 % is 
type AB.
</P><P>
The current blood donation and reception system in transfusion medicine bases on this comparison 
of blood groups. It requires to test the blood of the involved people at least once for the donor, once 
for the recipient and additionally right before the supply in form of a bedside compatibility test. 
These tests are time consuming, which can be critical in some situations for the life of the patient.
</P><P>
Although the blood groups of donations are roughly equally distributed as the overall distribution in 
a country, rare blood preservations may get scarce quickly dependent on the case of emergency. 
When a patient with a rare blood group needs a big amount of blood preservations the stock can 
diminish rapidly. In the worst case, this then may lead to the inability to supply a patient with the 
correct blood type, which may have direct influence to the chance of survival. On the other hand 
preservations of blood groups with higher frequency are excessively available and may be useless 
during their storage life. Due to this phenomena huge amounts of unused blood preservations are 
discarded continuously in blood institutes, due to the impossibility to use them.
</P><P>
However, blood groups can be converted. As shown in figure 1 the nature of an ABO blood group is 
the composition of oligosaccharides that are physically exposed on the exterior of red blood cells. 
Specific glycosidases, derived from bacteria can remove monosaccharides from these 
oligosaccharides and therefore convert the blood groups A, B and AB to O. In our case we wanted to 
use the following enzymes: N-acetylgalactosaminidase (NAGA) from <I>Elizabethkingia meningoseptica</I> 
to convert type A to O, α-Galactosidase (αGAL) from <I>Bacteriodes fragilis</I> to convert type B to O [3]. To 
convert type AB to O one could apply both enzymes or another enzyme we used: Endo-β-
galactosidase (EABase) from <I>Clostridium perfringens</I>. This process could be realized technically by 
immobilizing the enzymes onto a column. To convert a blood preservation, it is only necessary to 
apply the preservation onto the column. The process of conversion can therefore get highly 
automatized.
</P><P>
So a new blood donation and reception system making use of converted blood cells could improve 
several aspects of the transfusion medicine. First of all the amount of blood tests would decrease. All 
donations would be immediately converted and the only blood test would be a blood quality control 
after conversion is done. Patients with rare blood groups now can be supplied sufficiently with blood 
preservations and there will not be a deficit of a certain blood group again. Due to the consequent 
conversion of blood cells, all blood preservations will be able to be used. This would result in a more 
efficient use of donated blood and in less disposal of preservations. Moreover, an automated process 
would result in faster handling and more efficient preservation supply of patients.
</P><P>
Last but not least, the possibility to supply preservations to every patient in nearly any amount and 
higher performance will save lives.
</P><H3>References</H3><P>
[1] <A href="http://www.uvm.edu/~uvmpr/?Page=news&amp;storyID=13259">Joshua E. Brown (22 February 2012). &quot;Blood Mystery Solved&quot;. University Of Vermont.</A> Retrieved
11 June 2012.
</P><P>
[2] (2014) <A href="http://en.wikipedia.org/wiki/Blood_type">http://en.wikipedia.org/wiki/Blood_type</A></P><P>
[3] <A href="http://www.nature.com/nbt/journal/v25/n4/abs/nbt1298.html">Liu, Q.P., Sulzenbacher, G., Yuan, H., Bennett, E.P., Pietz, G., Saunders, K., Spence, J., Nudelman, E., Levery, S.B., White, T., Neveu, J.M., Lane, W.S., Bourne, Y., Olsson, M.L., Henrissat, B. &amp; Clausen, H. (2007). Bacterial glycosidases for the production of universal red blood cells. Nature biotechnology 25, 454-464.</A></P></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Tuebingen/Project/Motivation">http://2014.igem.org/Team:Tuebingen/Project/Motivation</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Tuebingen/Project/Motivation" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Tuebingen/Project/Motivation" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Tuebingen/Project/Motivation&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Tuebingen/Project/Motivation&amp;oldid=400591" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>